Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis

Journal article


Ademowo, Opeyemi S, Hernandez, Belinda, Collins, Emily, Rooney, Cathy, Fearon, Ursula, van Kuijk, Arno W, Tak, Paul-P, Gerlag, Danielle M, FitzGerald, Oliver and Pennington, Stephen R 2014. Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis. Annals of the Rheumatic Diseases. 75 (1), pp. 234-241. https://doi.org/10.1136/annrheumdis-2014-205417
AuthorsAdemowo, Opeyemi S, Hernandez, Belinda, Collins, Emily, Rooney, Cathy, Fearon, Ursula, van Kuijk, Arno W, Tak, Paul-P, Gerlag, Danielle M, FitzGerald, Oliver and Pennington, Stephen R
Abstract

Biological therapies, which include antitumour necrosis factor-α and T-cell inhibitors, are potentially effective treatments for psoriatic arthritis (PsA) but are costly and may induce a number of side effects. Response to treatment in PsA is variable and difficult to predict. Here, we sought to identify a panel of protein biomarkers that could be used to predict which patients diagnosed with PsA will respond to biologic treatment. An integrated discovery to targeted proteomics approach was used to investigate the protein profiles of good and non-responders to biological treatments in patients with PsA. Reverse-phase liquid chromatography coupled to tandem mass spectrometry was used to generate protein profiles of synovial tissue obtained at baseline from 10 patients with PsA. Targeted proteomics using multiple reaction monitoring (MRM) was used to confirm and prevalidate a potential protein biomarker panel in 18 and 7 PsA patient samples, respectively. A panel of 107 proteins was selected, and targeted mass spectrometry MRM assays were successfully developed for 57 of the proteins. The 57 proteins include S100-A8, S100-A10, Ig kappa chain C fibrinogen-α and γ, haptoglobin, annexin A1 and A2, collagen alpha-2, vitronectin, and alpha-1 acid glycoprotein. The proteins were measured simultaneously and confirmed to be predictive of response to treatment with an area under the curve of 0.76. In a blinded study using a separate cohort of patients, the panel was able to predict response to treatment. The approach reported here and the initial data provide evidence that a multiplexed protein assay of a panel of biomarkers that predict response to treatment could be developed.

KeywordsProteomics; Biomarker discovery; Psoriatic arthritis; Anti-TNF-alpha therapy
Year2014
JournalAnnals of the Rheumatic Diseases
Journal citation75 (1), pp. 234-241
PublisherBMJ
ISSN0003-4967
1468-2060
Digital Object Identifier (DOI)https://doi.org/10.1136/annrheumdis-2014-205417
Web address (URL)http://hdl.handle.net/10545/624544
http://creativecommons.org/licenses/by-nc-nd/4.0/
hdl:10545/624544
Publication dates03 Sep 2014
Publication process dates
Deposited05 Mar 2020, 09:45
Accepted2013
Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

ContributorsUniversity College Dublin, Ireland
File
File Access Level
Open
File
File Access Level
Open
Permalink -

https://repository.derby.ac.uk/item/92376/discovery-and-confirmation-of-a-protein-biomarker-panel-with-potential-to-predict-response-to-biological-therapy-in-psoriatic-arthritis

Download files

  • 61
    total views
  • 0
    total downloads
  • 0
    views this month
  • 0
    downloads this month

Export as

Related outputs

Advances in clinical application of lipidomics in healthy ageing and healthy longevity medicine
Ademowo, S., Wenk, M. R. and Maier, A. B. 2024. Advances in clinical application of lipidomics in healthy ageing and healthy longevity medicine. Ageing Research Reviews. 100, pp. 1-8. https://doi.org/10.1016/j.arr.2024.102432
Effects of carotenoids on mitochondrial dysfunction
Ademowo, S., Oyebode, O., Edward, R., Conway, M., Griffiths, H. and Dias, I. H. K. 2024. Effects of carotenoids on mitochondrial dysfunction. Biochemical Society Transactions. 52 (1), p. 65–74. https://doi.org/10.1042/BST20230193
Circulating oxysterols in Alzheimer’s disease: a systematic review and meta-analysis
Ademowo, OS. and Dias, I. H. K 2022. Circulating oxysterols in Alzheimer’s disease: a systematic review and meta-analysis. Redox Experimental Medicine. 2022 (1), pp. 116 -126. https://doi.org/10.1530/REM-22-0009
Inflammation, lipid (per)oxidation, and redox regulation
Dias, Irundika H.K., Milic, Ivana, Heiss, Christian, Ademowo, Opeyemi S., Polidori, Maria Cristina, Devitt, Andrew and Griffiths, Helen R. 2020. Inflammation, lipid (per)oxidation, and redox regulation. Antioxidant and Redox Signaling. https://doi.org/10.1089/ars.2020.8022
Nutritional hormesis in a modern environment
Ademowo, O. Stella, Dias, H. K. Irundika, Pararasa, Chathyan and Griffiths, Helen R. 2018. Nutritional hormesis in a modern environment. in: The Science of Hormesis in Health and Longevity Elsevier.
Partial mitigation of oxidized phospholipid-mediated mitochondrial dysfunction in neuronal cells by oxocarotenoids
Ademowo, Opeyemi S., Dias, Irundika H.K., Diaz-Sanchez, Lorena, Sanchez-Aranguren, Lissette, Stahl, Wilhelm and Griffiths, Helen R. 2020. Partial mitigation of oxidized phospholipid-mediated mitochondrial dysfunction in neuronal cells by oxocarotenoids. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-190923
Distribution of plasma oxidised phosphatidylcholines in chronic kidney disease and periodontitis as a co-morbidity
Ademowo, Opeyemi Stella, Sharma, Praveen, Cockwell, Paul, Reis, Ana, Chapple, Iain L., Griffiths, Helen R. and Dias, Irundika H.K. 2019. Distribution of plasma oxidised phosphatidylcholines in chronic kidney disease and periodontitis as a co-morbidity. Free Radical Biology and Medicine. 146, pp. 130-138. https://doi.org/10.1016/j.freeradbiomed.2019.10.012
Lipid (per) oxidation in mitochondria: an emerging target in the ageing process?
Ademowo, O. S., Dias, H. K. I., Burton, D. G. A. and Griffiths, H. R. 2017. Lipid (per) oxidation in mitochondria: an emerging target in the ageing process? Biogerontology. 18 (6), pp. 859-879. https://doi.org/10.1007/s10522-017-9710-z
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
Egea, Javier, Fabregat, Isabel, Frapart, Yves M., Ghezzi, Pietro, Görlach, Agnes, Kietzmann, Thomas, Kubaichuk, Kateryna, Knaus, Ulla G., Lopez, Manuela G., Olaso-Gonzalez, Gloria, Petry, Andreas, Schulz, Rainer, Vina, Jose, Winyard, Paul, Abbas, Kahina, Ademowo, Opeyemi S., Afonso, Catarina B., Andreadou, Ioanna, Antelmann, Haike, Antunes, Fernando, Aslan, Mutay, Bachschmid, Markus M., Barbosa, Rui M., Belousov, Vsevolod, Berndt, Carsten, Bernlohr, David, Bertrán, Esther, Bindoli, Alberto, Bottari, Serge P., Brito, Paula M., Carrara, Guia, Casas, Ana I., Chatzi, Afroditi, Chondrogianni, Niki, Conrad, Marcus, Cooke, Marcus S., Costa, João G., Cuadrado, Antonio, My-Chan Dang, Pham, De Smet, Barbara, Debelec–Butuner, Bilge, Dias, Irundika H.K., Dunn, Joe Dan, Edson, Amanda J., El Assar, Mariam, El-Benna, Jamel, Ferdinandy, Péter, Fernandes, Ana S., Fladmark, Kari E., Förstermann, Ulrich, Giniatullin, Rashid, Giricz, Zoltán, Görbe, Anikó, Griffiths, Helen, Hampl, Vaclav, Hanf, Alina, Herget, Jan, Hernansanz-Agustín, Pablo, Hillion, Melanie, Huang, Jingjing, Ilikay, Serap, Jansen-Dürr, Pidder, Jaquet, Vincent, Joles, Jaap A., Kalyanaraman, Balaraman, Kaminskyy, Danylo, Karbaschi, Mahsa, Kleanthous, Marina, Klotz, Lars-Oliver, Korac, Bato, Korkmaz, Kemal Sami, Koziel, Rafal, Kračun, Damir, Krause, Karl-Heinz, Křen, Vladimír, Krieg, Thomas, Laranjinha, João, Lazou, Antigone, Li, Huige, Martínez-Ruiz, Antonio, Matsui, Reiko, McBean, Gethin J., Meredith, Stuart P., Messens, Joris, Miguel, Verónica, Mikhed, Yuliya, Milisav, Irina, Milković, Lidija, Miranda-Vizuete, Antonio, Mojović, Miloš, Monsalve, María, Mouthuy, Pierre-Alexis, Mulvey, John, Münzel, Thomas, Muzykantov, Vladimir, Nguyen, Isabel T.N., Oelze, Matthias, Oliveira, Nuno G., Palmeira, Carlos M., Papaevgeniou, Nikoletta, Pavićević, Aleksandra, Pedre, Brandán, Peyrot, Fabienne, Phylactides, Marios, Pircalabioru, Gratiela G., Pitt, Andrew R., Poulsen, Henrik E., Prieto, Ignacio, Rigobello, Maria Pia, Robledinos-Antón, Natalia, Rodríguez-Mañas, Leocadio, Rolo, Anabela P., Rousset, Francis, Ruskovska, Tatjana, Saraiva, Nuno, Sasson, Shlomo, Schröder, Katrin, Semen, Khrystyna, Seredenina, Tamara, Shakirzyanova, Anastasia, Smith, Geoffrey L., Soldati, Thierry, Sousa, Bebiana C., Spickett, Corinne M., Stancic, Ana, Stasia, Marie José, Steinbrenner, Holger, Stepanić, Višnja, Steven, Sebastian, Tokatlidis, Kostas, Tuncay, Erkan, Turan, Belma, Ursini, Fulvio, Vacek, Jan, Vajnerova, Olga, Valentová, Kateřina, Van Breusegem, Frank, Varisli, Lokman, Veal, Elizabeth A., Yalçın, A. Suha, Yelisyeyeva, Olha, Žarković, Neven, Zatloukalová, Martina, Zielonka, Jacek, Touyz, Rhian M., Papapetropoulos, Andreas, Grune, Tilman, Lamas, Santiago, Schmidt, Harald H.H.W., Di Lisa, Fabio and Daiber, Andreas 2017. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biology. 13, pp. 94-162. https://doi.org/10.1016/j.redox.2017.05.007
Phospholipid oxidation and carotenoid supplementation in Alzheimer’s disease patients
Ademowo, O.S., Dias, H.K.I., Milic, I., Devitt, A., Moran, R., Mulcahy, R., Howard, A.N., Nolan, J.M. and Griffiths, H.R. 2017. Phospholipid oxidation and carotenoid supplementation in Alzheimer’s disease patients. Free Radical Biology and Medicine. 108, pp. 77-85. https://doi.org/10.1016/j.freeradbiomed.2017.03.008